Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOL-DP-o-08 in Endometriosis Syndrome
NCT04174911Phase 2Withdrawn
- Sponsor
- BOL Pharma
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of BOL-DP-o-08 in endometriosis, sponsored by BOL Pharma. Planned start Jan 2019; status: withdrawn.
02
Drugs
BOL-DP-o-08
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04174911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04174911.